Key terms
About ALGN
Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ALGN news
Today
6:13am ET
Align Tech Announces $150 Million Stock Buyback Plan
Yesterday
8:09am ET
Align Technology price target raised to $360 from $344 at Morgan Stanley
Yesterday
7:33am ET
Align Technology price target raised to $349 from $327 at Leerink
Yesterday
6:55am ET
Align Technology price target raised to $375 from $355 at Piper Sandler
Yesterday
6:28am ET
Align Technology price target raised to $370 from $333 at Baird
Apr 24
4:03pm ET
Align Technology sees FY24 revenue growth 6%-8%, consensus $4.05B
Apr 24
4:02pm ET
Align Technology sees Q2 revenue $1.03B-$1.05B, consensus $1.03B
Apr 24
4:02pm ET
Align Technology reports Q1 adjusted EPS $2.14, consensus $1.97
Apr 24
2:19pm ET
Notable companies reporting after market close
Apr 18
7:40am ET
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN) and Bruker (BRKR)
Apr 18
7:23am ET
Align Technology price target raised to $400 from $350 at Stifel
Apr 18
7:10am ET
Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (SAGE), Poseida Therapeutics (PSTX) and Align Tech (ALGN)
Apr 08
8:08am ET
Align Technology launches integrated consumer campaign
Mar 15
8:41am ET
Align Technology price target raised to $350 from $340 at Stifel
Mar 13
9:55am ET
Early notable gainers among liquid option names on March 13th
Mar 13
7:00am ET
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Legend Biotech (LEGN) and Aslan Pharmaceuticals (ASLN)
Mar 13
6:47am ET
Align Technology price target raised to $355 from $335 at Piper Sandler
Feb 26
9:34am ET
Moderna downgraded, Gap upgraded: Wall Street’s top analyst calls
Feb 26
8:00am ET
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Exact Sciences (EXAS) and Springworks Therapeutics (SWTX)
Feb 26
6:28am ET
Align Technology initiated with a Market Perform at Leerink
Feb 22
10:19am ET
Align Technology says court grants summary judgement in favor of company
Feb 16
7:10am ET
Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Bio-Rad Laboratories (BIO)
Feb 01
1:25pm ET
Maintaining Sell Rating on Align Technology Amid Stagnant Demand and Competitive Challenges
Feb 01
9:55am ET
Early notable gainers among liquid option names on February 1st
Feb 01
8:45am ET
Align Technology price target raised to $335 from $290 at Piper Sandler
Feb 01
8:10am ET
Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Thermo Fisher (TMO) and Align Tech (ALGN)
Feb 01
8:05am ET
Align Tech (ALGN) Gets a Buy from Piper Sandler
Feb 01
7:58am ET
Align Technology price target raised to $340 from $285 at Stifel
Feb 01
7:31am ET
Align Technology price target raised to $215 from $180 at BofA
Feb 01
7:28am ET
Align Technology price target raised to $280 from $260 at UBS
Feb 01
6:32am ET
Align Technology price target raised to $333 from $310 at Baird
No recent press releases are available for ALGN
ALGN Financials
Key terms
Ad Feedback
ALGN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ALGN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range